Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors

D. Tepper, S. M. Greenberg, M. Packer, M. Gheorghiade, J. Young

Research output: Contribution to journalArticle

Abstract

In this section, the use of digoxin is discussed. Despite evidence from controlled trials supporting its value, the use of digoxin remains controversial. The withdrawal of digoxin carries considerable risk for patients with chronic heart failure and impaired systolic function who have remained clinically stable while receiving digoxin and angiotensin- converting-enzyme inhibitors.

Original languageEnglish (US)
Pages (from-to)54
Number of pages1
JournalCardiovascular Reviews and Reports
Volume14
Issue number9
StatePublished - 1993

Fingerprint

Digoxin
Angiotensin-Converting Enzyme Inhibitors
Heart Failure
Systolic Heart Failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. / Tepper, D.; Greenberg, S. M.; Packer, M.; Gheorghiade, M.; Young, J.

In: Cardiovascular Reviews and Reports, Vol. 14, No. 9, 1993, p. 54.

Research output: Contribution to journalArticle

Tepper, D. ; Greenberg, S. M. ; Packer, M. ; Gheorghiade, M. ; Young, J. / Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. In: Cardiovascular Reviews and Reports. 1993 ; Vol. 14, No. 9. pp. 54.
@article{80845bfd5248434b88956b347e9473c4,
title = "Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors",
abstract = "In this section, the use of digoxin is discussed. Despite evidence from controlled trials supporting its value, the use of digoxin remains controversial. The withdrawal of digoxin carries considerable risk for patients with chronic heart failure and impaired systolic function who have remained clinically stable while receiving digoxin and angiotensin- converting-enzyme inhibitors.",
author = "D. Tepper and Greenberg, {S. M.} and M. Packer and M. Gheorghiade and J. Young",
year = "1993",
language = "English (US)",
volume = "14",
pages = "54",
journal = "Cardiovascular Reviews and Reports",
issn = "0197-3118",
publisher = "Le Jacq Communications, Inc.",
number = "9",

}

TY - JOUR

T1 - Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors

AU - Tepper, D.

AU - Greenberg, S. M.

AU - Packer, M.

AU - Gheorghiade, M.

AU - Young, J.

PY - 1993

Y1 - 1993

N2 - In this section, the use of digoxin is discussed. Despite evidence from controlled trials supporting its value, the use of digoxin remains controversial. The withdrawal of digoxin carries considerable risk for patients with chronic heart failure and impaired systolic function who have remained clinically stable while receiving digoxin and angiotensin- converting-enzyme inhibitors.

AB - In this section, the use of digoxin is discussed. Despite evidence from controlled trials supporting its value, the use of digoxin remains controversial. The withdrawal of digoxin carries considerable risk for patients with chronic heart failure and impaired systolic function who have remained clinically stable while receiving digoxin and angiotensin- converting-enzyme inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0027429653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027429653&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 54

JO - Cardiovascular Reviews and Reports

JF - Cardiovascular Reviews and Reports

SN - 0197-3118

IS - 9

ER -